News Website

LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.

Long interspersed element 1 (LINE-1) retrotransposons are repetitive sequences that can move within the genome by an autonomous mechanism. To limit their mutagenic potential, benign cells restrict LINE-1 expression through …

Published: March 6, 2025, midnight

Read Full Article

Deep-learning radiomics model aids in ovarian cancer diagnosis - AuntMinnie

Deep-learning radiomics model aids in ovarian cancer diagnosis AuntMinnie

Published: March 5, 2025, 10:48 p.m.

Read Full Article

Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer - OncLive

Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer OncLive

Published: March 5, 2025, 8:17 p.m.

Read Full Article

When to go for colon cancer screening - Bona Magazine

When to go for colon cancer screening Bona Magazine

Published: March 5, 2025, 5:03 p.m.

Read Full Article

ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer - Medpage Today

ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer Medpage Today

Published: March 5, 2025, 4:47 p.m.

Read Full Article

Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports - AboutLawsuits.com

Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports AboutLawsuits.com

Published: March 5, 2025, 4 p.m.

Read Full Article

20 years ago I'd be dead - but I've beaten cancer & doing Race for Life - Lancashire Evening Post

20 years ago I'd be dead - but I've beaten cancer & doing Race for Life Lancashire Evening Post

Published: March 5, 2025, 3:08 p.m.

Read Full Article

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com

Published: March 5, 2025, 11:04 a.m.

Read Full Article

Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - Oncology Nurse Advisor

Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer Oncology Nurse Advisor

Published: March 5, 2025, 5 a.m.

Read Full Article

Newly discovered biomarkers could improve endometrial cancer treatment - Medical Xpress

Newly discovered biomarkers could improve endometrial cancer treatment Medical Xpress

Published: March 4, 2025, 8:55 p.m.

Read Full Article

Latest Articles

LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.

Deep-learning radiomics model aids in ovarian cancer diagnosis - AuntMinnie

Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer - OncLive

When to go for colon cancer screening - Bona Magazine

ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer - Medpage Today

Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports - AboutLawsuits.com

20 years ago I'd be dead - but I've beaten cancer & doing Race for Life - Lancashire Evening Post

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com

Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - Oncology Nurse Advisor

Newly discovered biomarkers could improve endometrial cancer treatment - Medical Xpress

Subscribe to Our Newsletter